The store will not work correctly when cookies are disabled.
3-(4-((2-bromo-5-fluorophenoxy)methyl)phenyl)propanoic acid
ID: ALA4743323
PubChem CID: 162645828
Max Phase: Preclinical
Molecular Formula: C16H14BrFO3
Molecular Weight: 353.19
Molecule Type: Unknown
Associated Items:
Names and Identifiers
Canonical SMILES: O=C(O)CCc1ccc(COc2cc(F)ccc2Br)cc1
Standard InChI: InChI=1S/C16H14BrFO3/c17-14-7-6-13(18)9-15(14)21-10-12-3-1-11(2-4-12)5-8-16(19)20/h1-4,6-7,9H,5,8,10H2,(H,19,20)
Standard InChI Key: FROMBFNPGOZGFH-UHFFFAOYSA-N
Molfile:
RDKit 2D
21 22 0 0 0 0 0 0 0 0999 V2000
6.8085 -19.1586 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.8074 -19.9781 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.5154 -20.3871 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.2251 -19.9776 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.2222 -19.1550 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.5136 -18.7497 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.9284 -18.7437 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.6376 -19.1496 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.3438 -18.7384 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.0531 -19.1443 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
10.3407 -17.9212 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
6.0993 -20.3861 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.3919 -19.9770 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
4.6839 -20.3850 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.9773 -19.9737 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.2697 -20.3810 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.2687 -21.1991 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.9810 -21.6081 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.6856 -21.1984 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.9832 -22.4253 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
3.9792 -19.1565 0.0000 Br 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
5 7 1 0
7 8 1 0
8 9 1 0
9 10 1 0
9 11 2 0
2 12 1 0
12 13 1 0
13 14 1 0
14 15 2 0
15 16 1 0
16 17 2 0
17 18 1 0
18 19 2 0
19 14 1 0
18 20 1 0
15 21 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 353.19 | Molecular Weight (Monoisotopic): 352.0110 | AlogP: 4.18 | #Rotatable Bonds: 6 |
Polar Surface Area: 46.53 | Molecular Species: ACID | HBA: 2 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 3 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 4.16 | CX Basic pKa: ┄ | CX LogP: 4.53 | CX LogD: 1.47 |
Aromatic Rings: 2 | Heavy Atoms: 21 | QED Weighted: 0.85 | Np Likeness Score: -0.68 |
References
1. Xu F,Zhao Y,Zhou H,Li C,Zhang X,Hou T,Qu L,Wei L,Wang J,Liu Y,Liang X. (2020) Synthesis and evaluation of 3-(4-(phenoxymethyl)phenyl)propanoic acid and N-phenylbenzenesulfonamide derivatives as FFA4 agonists., 30 (24): [PMID:33127539] [10.1016/j.bmcl.2020.127650] |